116 related articles for article (PubMed ID: 1545106)
1. Efficacy of autologous bone marrow transplants as treatment for breast cancer.
Uzych L
J Am Med Womens Assoc (1972); 1992; 47(1):3. PubMed ID: 1545106
[No Abstract] [Full Text] [Related]
2. Tide turning against autologous bone marrow transplants in federal appellate courts.
Margolis RE
Healthspan; 1993 Jun; 10(6):21-2. PubMed ID: 10127304
[No Abstract] [Full Text] [Related]
3. BCBS must pay autologous bone marrow transplants.
Margolis RE
Healthspan; 1991 Apr; 8(4):22-3. PubMed ID: 10183479
[No Abstract] [Full Text] [Related]
4. Federal courts still split on autologous bone marrow transplants.
Margolis RE
Healthspan; 1992 Dec; 9(11):20-2. PubMed ID: 10123554
[No Abstract] [Full Text] [Related]
5. Autologous bone marrow transplants.
Rose LJ
Health Aff (Millwood); 2002; 21(2):308. PubMed ID: 11900184
[No Abstract] [Full Text] [Related]
6. Insurance payments for bone marrow transplantation in metastatic breast cancer.
van Amerongen D
N Engl J Med; 2000 Apr; 342(15):1138-9. PubMed ID: 10766588
[No Abstract] [Full Text] [Related]
7. Two views on HDCT-ABMT breast cancer treatment controversy. Too experimental for insurers--or just too expensive?
Carter RD; Coleman DM; Bennett JE
Healthspan; 1992 Jan; 9(1):10-5. PubMed ID: 10117134
[No Abstract] [Full Text] [Related]
8. Experimental definition in Adams leads to controversy.
Gordon DE; Eccles RN
Healthspan; 1992 Jan; 9(1):15-20. PubMed ID: 10183633
[No Abstract] [Full Text] [Related]
9. Perspectives. Indefinite results in ABMT (autologous bone marrow transplantation) trials add to challenges for practice standards, quality assurance in cancer care.
Cunningham R
Med Health; 1999 Apr; 53(16):suppl 1-4. PubMed ID: 10387749
[No Abstract] [Full Text] [Related]
10. Autologous bone marrow transplantation for advanced breast cancer.
Med Lett Drugs Ther; 1991 May; 33(843):39-40. PubMed ID: 2014014
[No Abstract] [Full Text] [Related]
11. Variations in insurance coverage for autologous bone marrow transplantation for breast cancer.
Krause KJ
N Engl J Med; 1994 Aug; 331(5):329; author reply 330-1. PubMed ID: 8068113
[No Abstract] [Full Text] [Related]
12. Health insurance: coverage of autologous bone marrow transplantation for breast cancer.
Jaggar SF
Oncology (Williston Park); 1996 Sep; 10(9):1329-32, 1337-8, 1340 passim. PubMed ID: 8882925
[No Abstract] [Full Text] [Related]
13. Insurance company forced to pay for autologous bone marrow transplant. Leonhardt v. Holden Business Forms Co.
Swisher KN
J Healthc Risk Manag; 1994; 14(2):40-3. PubMed ID: 10184154
[No Abstract] [Full Text] [Related]
14. 3rd Circuit keeps split alive on autologous bone marrow transplants for breast cancer. Clark v. K-Mart Corporation.
Margolis RE
Healthspan; 1992; 9(7):21-2. PubMed ID: 10183724
[No Abstract] [Full Text] [Related]
15. The role of bone marrow transplantation in the management of advanced local disease.
Safah H; Weiner RS
Surg Oncol Clin N Am; 1995 Oct; 4(4):735-49. PubMed ID: 8535908
[TBL] [Abstract][Full Text] [Related]
16. Defining experimental therapy--a third-party payer's dilemma.
Newcomer LN
N Engl J Med; 1990 Dec; 323(24):1702-4. PubMed ID: 2233969
[No Abstract] [Full Text] [Related]
17. Blues taking part in testing of new breast cancer treatment.
Kenkel PJ
Mod Healthc; 1991 Dec 23-30; 21(51):10. PubMed ID: 10115294
[No Abstract] [Full Text] [Related]
18. Reimbursement for solid tumor autologous bone marrow transplantation trials: a strategy for ensuring continuation of a promising therapy.
Spitzer TR; Swain SM; Lippman ME; Deeg HJ
Cancer Invest; 1991; 9(1):93-7. PubMed ID: 2013001
[No Abstract] [Full Text] [Related]
19. Health insurance coverage for emerging medical technologies: a new approach.
Puzio D
Tort Trial Insur Pract Law J; 2003; 38(4):1019-47. PubMed ID: 14503539
[No Abstract] [Full Text] [Related]
20. ABMT and breast cancer: what have we learned?
Brown E
Physician Exec; 1999; 25(4):86-8. PubMed ID: 10557495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
